Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Craneware ( (GB:CRW) ) has provided an update.
Craneware has repurchased a series of its own ordinary shares between 31 March and 2 April 2026 under a previously announced buyback programme, executing trades on both AIMX and the London Stock Exchange at volume-weighted average prices in the low to mid-1300 pence range. The company will hold the repurchased shares in treasury, leaving 35,002,610 ordinary shares in issue and redefining the total voting rights base, a move that can influence earnings per share metrics and shareholder ownership thresholds under UK disclosure rules.
By consolidating shares into treasury rather than cancelling them, Craneware retains flexibility for future capital management actions such as reissuance for employee incentives or potential funding needs. The adjustment to the voting rights denominator may prompt some investors to reassess and potentially update their disclosed holdings to remain compliant with regulatory transparency requirements.
The most recent analyst rating on (GB:CRW) stock is a Hold with a £1599.00 price target. To see the full list of analyst forecasts on Craneware stock, see the GB:CRW Stock Forecast page.
Spark’s Take on CRW Stock
According to Spark, TipRanks’ AI Analyst, CRW is a Neutral.
The score is driven primarily by solid financial performance (strong margins and a low-debt balance sheet), but it is meaningfully weighed down by weak technical momentum (price below key moving averages with negative MACD) and a relatively high P/E that limits valuation support despite the dividend yield.
To see Spark’s full report on CRW stock, click here.
More about Craneware
Craneware plc is a healthcare financial performance and operational transformation specialist that provides cloud-based software and analytics to hospitals and health systems. Its Trisus platform unifies revenue and margin intelligence with advanced analytics, helping healthcare organizations optimize financial sustainability and strategic growth while simplifying complex finance and operational workflows.
Average Trading Volume: 225,160
Technical Sentiment Signal: Sell
Current Market Cap: £471.1M
Find detailed analytics on CRW stock on TipRanks’ Stock Analysis page.